CROs, Convergence, and Commercial Opportunities
CROs, Convergence, and Commercial Opportunities
Insight

CROs, Convergence, and Commercial Opportunities

How industry convergence is creating win/win opportunities for contract research and life sciences organizations

With the Contract Research Organization(CRO) sector experiencing modest growth in recent years, many are starting to explore whether ongoing convergence in the U.S. healthcare industry may be creating opportunities for higher revenue growth. Our research suggests that significant untapped advantages may result from expanding the existing strategic relationships between CROs and their life sciences clients, and, thereby, creating new value streams.

CROs, Convergence, and Commercial Opportunities

How industry convergence is creating win/win opportunities for contract research and life sciences organizations.

Related content


KPMG Healthcare & Life Sciences Institute

Register to receive timely insights